Flunisolide Hemihydrate is a glucocorticoid class inhaled corticosteroid used primarily as a prophylactic therapy for the maintenance treatment of asthma to reduce airway inflammation. Laboratories require… Read more
Flunisolide Hemihydrate is a glucocorticoid class inhaled corticosteroid used primarily as a prophylactic therapy for the maintenance treatment of asthma to reduce airway inflammation. Laboratories require high-quality reference standards of Flunisolide Hemihydrate, along with its related pharmacopeial and non-pharmacopeial impurities, to support rigorous analytical testing and quality control procedures. These compounds are essential for accurate impurity profiling and method validation during pharmaceutical development. Furthermore, researchers utilize stable isotope-labelled analogues of this drug as internal standards in pharmacokinetic studies to ensure precision when quantifying concentrations in complex biological matrices. Accessing a comprehensive range of these verified standards enables the precise identification and measurement of degradation products and metabolic profiles, ensuring compliance with regulatory requirements throughout the drug development lifecycle.